NO2941257T3 - - Google Patents
Info
- Publication number
- NO2941257T3 NO2941257T3 NO14700238A NO14700238A NO2941257T3 NO 2941257 T3 NO2941257 T3 NO 2941257T3 NO 14700238 A NO14700238 A NO 14700238A NO 14700238 A NO14700238 A NO 14700238A NO 2941257 T3 NO2941257 T3 NO 2941257T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305009 | 2013-01-07 | ||
| EP14700238.0A EP2941257B1 (de) | 2013-01-07 | 2014-01-07 | Krankheitstherapie mit einer tolerogenen pharmazeutischen zubereitung |
| PCT/EP2014/050167 WO2014106666A1 (en) | 2013-01-07 | 2014-01-07 | Disease therapy using a tolerogenic pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2941257T3 true NO2941257T3 (de) | 2018-04-28 |
Family
ID=47559360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14700238A NO2941257T3 (de) | 2013-01-07 | 2014-01-07 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10653758B2 (de) |
| EP (1) | EP2941257B1 (de) |
| CY (1) | CY1119957T1 (de) |
| DK (1) | DK2941257T3 (de) |
| ES (1) | ES2657675T3 (de) |
| HR (1) | HRP20180359T1 (de) |
| HU (1) | HUE038211T2 (de) |
| LT (1) | LT2941257T (de) |
| NO (1) | NO2941257T3 (de) |
| PL (1) | PL2941257T3 (de) |
| PT (1) | PT2941257T (de) |
| RS (1) | RS56906B1 (de) |
| SI (1) | SI2941257T1 (de) |
| WO (1) | WO2014106666A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| US11512289B2 (en) | 2015-02-18 | 2022-11-29 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| WO2017141243A1 (en) * | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| CN113106053A (zh) * | 2015-04-21 | 2021-07-13 | 恩立夫克治疗有限责任公司 | 治疗性汇集的血液凋亡细胞制剂与其用途 |
| FR3082730B1 (fr) * | 2018-06-21 | 2022-04-22 | Med Inn Pharma | Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202098A1 (en) * | 2001-01-31 | 2005-09-15 | Tolaren | Disease therapy using dying or dead cells |
| WO2006120439A2 (en) * | 2005-05-10 | 2006-11-16 | Avaris Ab | Cellular vaccine and use thereof |
| CA2664567C (en) | 2006-10-04 | 2016-04-26 | Dana-Farber Cancer Institute, Inc. | Tumor immunity |
| EP2201954A1 (de) * | 2008-12-18 | 2010-06-30 | Aposcience AG | Pharmazeutisches Präparat |
-
2014
- 2014-01-07 WO PCT/EP2014/050167 patent/WO2014106666A1/en active Application Filing
- 2014-01-07 PT PT147002380T patent/PT2941257T/pt unknown
- 2014-01-07 ES ES14700238.0T patent/ES2657675T3/es active Active
- 2014-01-07 LT LTEP14700238.0T patent/LT2941257T/lt unknown
- 2014-01-07 DK DK14700238.0T patent/DK2941257T3/en active
- 2014-01-07 RS RS20180211A patent/RS56906B1/sr unknown
- 2014-01-07 HU HUE14700238A patent/HUE038211T2/hu unknown
- 2014-01-07 PL PL14700238T patent/PL2941257T3/pl unknown
- 2014-01-07 EP EP14700238.0A patent/EP2941257B1/de active Active
- 2014-01-07 US US14/759,452 patent/US10653758B2/en active Active
- 2014-01-07 NO NO14700238A patent/NO2941257T3/no unknown
- 2014-01-07 SI SI201430584T patent/SI2941257T1/en unknown
-
2018
- 2018-02-27 HR HRP20180359TT patent/HRP20180359T1/hr unknown
- 2018-02-27 CY CY20181100232T patent/CY1119957T1/el unknown
-
2020
- 2020-04-14 US US16/847,829 patent/US11793865B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2941257T3 (pl) | 2018-05-30 |
| ES2657675T3 (es) | 2018-03-06 |
| EP2941257B1 (de) | 2017-11-29 |
| US20200237884A1 (en) | 2020-07-30 |
| HRP20180359T1 (hr) | 2018-05-04 |
| DK2941257T3 (en) | 2018-02-26 |
| SI2941257T1 (en) | 2018-03-30 |
| WO2014106666A1 (en) | 2014-07-10 |
| HUE038211T2 (hu) | 2018-10-29 |
| RS56906B1 (sr) | 2018-05-31 |
| LT2941257T (lt) | 2018-02-26 |
| EP2941257A1 (de) | 2015-11-11 |
| US20150343039A1 (en) | 2015-12-03 |
| CY1119957T1 (el) | 2018-12-12 |
| US10653758B2 (en) | 2020-05-19 |
| US11793865B2 (en) | 2023-10-24 |
| PT2941257T (pt) | 2018-03-06 |